Cargando…
New emerging therapies in the management of chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is considered incurable despite advances in management strategies. New drugs targeting cell pathways are currently being developed for the efficient management of CLL. Various strategies involving different targets have been developed, or are currently in the devel...
Autores principales: | Li, Xiao-Lin, Zhang, Ci-Xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103901/ https://www.ncbi.nlm.nih.gov/pubmed/27899962 http://dx.doi.org/10.3892/ol.2016.5108 |
Ejemplares similares
-
Update in the management of chronic lymphocytic leukemia
por: Maddocks, Kami J, et al.
Publicado: (2009) -
New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
por: Laurenti, Luca, et al.
Publicado: (2016) -
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies
por: Rivera, Daniel, et al.
Publicado: (2022) -
The Emerging Role of Ofatumumab in the Treatment of Chronic Lymphocytic Leukemia
por: Nabhan, Chadi, et al.
Publicado: (2011) -
Precision Medicine Management of Chronic Lymphocytic Leukemia
por: Moia, Riccardo, et al.
Publicado: (2020)